Literature DB >> 24644236

Truncal fat distribution correlates with decreased vital capacity in Duchenne muscular dystrophy.

Craig A Canapari1, Nick Barrowman, Lynda Hoey, Scott W Walker, Elise Townsend, Brian S Tseng, Sherri L Katz.   

Abstract

BACKGROUND: Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder associated with progressive muscle weakness and respiratory failure. Oral corticosteroids are the mainstay of treatment, but are associated with obesity with a central distribution. This study is designed to determine the relationship between body mass index, central adiposity, and lung function in subjects with DMD.
METHODS: Retrospective fat distribution data was obtained in boys with DMD from studies using dual X-ray absorptiometry (DXA). Fat distribution data was reviewed at two tertiary academic institutions and compared with concurrent height, weight, body mass index (BMI), measures of lung function, and sleep study data when available. Truncal fat mass used as a measure of central adiposity.
RESULTS: Forty-four subjects (age 12.0 ± 3.4 years) were included. Mean BMI was 22.1 ± 5.9 kg/m(2) . Sixty-eight percent (30 patients) were on corticosteroid therapy. Truncal fat mass percentage was inversely correlated with forced vital capacity (% predicted FVC) (Pearson coefficient -0.37, P = 0.01). Linear regression showed that truncal fat distribution, but not total fat mass, age or corticosteroid use negatively predicted FVC (r(2)  = 0.24, P = 0.048). BMI had a positive effect (P = 0.04). However, fat distribution did not predict the rate of change of lung function in a smaller sample. Fat distribution, BMI, or age did not predict measures of sleep disordered breathing.
CONCLUSIONS: Truncal fat distribution is a significant predictor of lower vital capacity in boys with DMD, whereas BMI has a positive effect.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  adiposity; body mass index; muscular dystrophy; restrictive lung disease

Mesh:

Year:  2014        PMID: 24644236     DOI: 10.1002/ppul.23004

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  4 in total

1.  The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy.

Authors:  Molly M Lamb; Bo Cai; Julie Royer; Shree Pandya; Aida Soim; Rodolfo Valdez; Carolyn DiGuiseppi; Katherine James; Nedra Whitehead; Holly Peay; Swamy Y Venkatesh; Dennis Matthews
Journal:  Am J Med Genet A       Date:  2018-09-26       Impact factor: 2.802

2.  Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids.

Authors:  Megan E Angliss; Kiara D Sclip; Leanne Gauld
Journal:  BMJ Open Respir Res       Date:  2020-02

3.  The Relationship between Obesity and Clinical Outcomes in Young People with Duchenne Muscular Dystrophy.

Authors:  Natassja Billich; Justine Adams; Kate Carroll; Helen Truby; Maureen Evans; Monique M Ryan; Zoe E Davidson
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

4.  Validity of bioelectrical impedance to estimate fat-free mass in boys with Duchenne muscular dystrophy.

Authors:  Evellyn C Grilo; Thais A Cunha; Ádila Danielly S Costa; Bárbara G M Araújo; Márcia Marília G D Lopes; Bruna L L Maciel; Camila X Alves; Karina M Vermeulen-Serpa; Mário Emílio T Dourado-Júnior; Lucia Leite-Lais; José Brandão-Neto; Sancha Helena L Vale
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.